vimarsana.com

Page 12 - ஒன்றுபட்டது உயிர் மருத்துவ இன்க் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Made in Taiwan COVID-19 vaccines could be ready in July, says minister | WSAU News/Talk 550 AM · 99 9 FM

By Syndicated Content Feb 26, 2021 3:55 AM TAIPEI (Reuters) - Taiwan could begin administering its home-made COVID-19 vaccines as early as July, the health minister said on Friday, with the island still awaiting the arrival of imported vaccines to begin its immunisation campaign. Taiwan has kept the pandemic well under control thanks to early and effective prevention, with less than 40 active cases, but it has not yet received any vaccines from abroad. Health Minister Chen Shih-chung told the parliament human trials had begun for two vaccines separately developed by Taiwan-based Medigen Vaccine Biologics and United Biomedical Inc Asia. If everything goes well, we could start administering domestically-made vaccines in July, Chen said without elaborating.

Made in Taiwan COVID-19 vaccines could be ready in July: health minister

Posted : 2021-02-26 19:54 People cross a street in Taipei, Feb. 23, 2021. EPA Taiwan could begin administering its home-made COVID-19 vaccines as early as July, the health minister said on Friday, with the island still awaiting the arrival of imported vaccines to begin its immunisation campaign. Taiwan has kept the pandemic well under control thanks to early and effective prevention, with less than 40 active cases, but it has not yet received any vaccines from abroad. Health Minister Chen Shih-chung told the parliament human trials had begun for two vaccines separately developed by Taiwan-based Medigen Vaccine Biologics and United Biomedical Inc Asia. If everything goes well, we could start administering domestically-made vaccines in July, Chen said without elaborating.

Race to roll out Covid-19 vaccines puts spotlight on logistical challenges

THE global rollout of Covid-19 vaccines has brought on a slew of new logistical challenges for vaccine manufacturers and logistics providers. While the capacity to meet the transport needs is adequate for now, it will not be enough as more players enter the Covid-19 vaccine manufacturing space, experts say. One of the three major challenges for vaccine makers is to get the vaccines out as quickly as possible, says Christina Yi, chief operating officer at US company Covaxx, a unit of United Biomedical Inc. “We cannot compromise on the safety and efficacy of our drugs. As such, manufacturers like Covaxx will take on additional business risks and costs that would not typically be economically viable in other circumstances such as moving forward with manufacturing multiple formulations on a large scale while waiting for the clinical trial results to determine the dosage amount,” she says during a panel discussion at the recent ­Covid-19 Vaccine Summit on Global Access and Distribu

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.